Dura mater-associated Creutzfeldt-Jakob disease: Experience from surveillance in the UK

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 77, Issue 7, 2006, Pages 880-882

  Heath, C A ^a   Barker, R A ^b   Esmonde, T F G ^c   Harvey, P ^d   Roberts, R ^e   Trend, P ^f   Head, M W ^a   Smith, C ^a   Bell, J E ^a   Ironside, J W ^a   Will, R G ^a   Knight, R S G ^a,g  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c ROYAL VICTORIA HOSPITAL   (United Kingdom)

^d Ninewells Hospital ^*  (United Kingdom)

^e NINEWELLS HOSPITAL   (United Kingdom)

^f ROYAL SURREY COUNTY HOSPITAL   (United Kingdom)

^g WESTERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

LYODURA;

ARTICLE; CONTROLLED STUDY; CREUTZFELDT JAKOB DISEASE; DURA MATER; EXPERIENCE; GRAFT RECIPIENT; HUMAN; INCUBATION TIME; MEDICAL LIABILITY; NONHUMAN; PATHOLOGY; PERIODIC MEDICAL EXAMINATION; PRIORITY JOURNAL; UNITED KINGDOM; ADULT; ANIMAL; CASE REPORT; DISEASE TRANSMISSION; FEMALE; HEALTH SURVEY; IATROGENIC DISEASE; MALE; SWINE; TIME; TRANSPLANTATION; XENOGRAFT;

ADULT; ANIMALS; CREUTZFELDT-JAKOB SYNDROME; DURA MATER; FEMALE; GREAT BRITAIN; HUMANS; IATROGENIC DISEASE; MALE; POPULATION SURVEILLANCE; SWINE; TIME FACTORS; TRANSPLANTATION, HETEROLOGOUS;

EID: 33745311131     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp.2005.073395     Document Type: Article

References (25)

1. Collins S, Law MG, Fletcher A, et al. Surgical treatment and risk of sporadic Creutzfeldt-Jakob disease: a case-control study. Lancet 1999;353:693-7.
2. Ward HJT, Everington D, Croes EA, et al. Sporadic Creutzfeldt-Jakob disease and surgery: a case-control study using community controls. Neurology 2002;59:543-8.
3. Will RG, Ironside JW, Zeidler M, et al. A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 1996;347:921-5.
4. Collinge J, Sidle KCL, Meads J, et al. Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD. Nature 1996;383:685-90.
5. Bruce ME, Will RG, Ironside JW, et al. Transmissions to mice indicate that 'new variant' CJD is caused by the BSE agent. Nature 1997;389:498-501.
6. Duffy P, Wolf J, Collins G, et al. Possible person-to-person transmission of Creutzfeldt-Jakob disease. N Engl J Med 1974;290:692-3.
7. Foncin JF, Gaches J, Cathala F, et al. Transmission iatrogene interhumaine possible de maladie de Creutzfeldt-Jakob avec atteinte des grains de cervelet. Rev Neurol 1980;136:280.
8. Prichard JW, Thadani V, Kalb R, et al. Rapidly progressive dementia in a patient who received a cadaveric dura mater graft. Morb Mortal Wkly Report 1987;34:49-55.
9. Thadani V, Penar PL, Partington J, et al. Creutzfeldt-Jakob disease probably acquired from a cadaveric dura mater graft. J Neurosurg 1988;69:766-9.
10. Will RG. A new variant of Creutzfeldt-Jakob disease in the UK. Proceedings of the Society for Veterinary Epidemiology and Preventative Medicine 1997:9-11 April 1997, University College, Chester, UK.
11. Will RG, Zeidler M, Stewart GE, et al. Diagnosis of new variant Creutzfeldt-Jakob disease. Ann Neurol 2000;47:575-82.
12. Esmonde T, Leuck CJS, Duchen LW, et al. CJD and lyophilised dura mater grafts: a report of two cases. J Neurol Neurosurg Psychiatry 1991;56:999-1000.
13. Willison HJ, Gale AN, McLaughlin JE. Creutzfeldt-Jakob disease following cadaveric dura mater graft. J Neurol Neurosurg Psychiatry 1991;54:940.
14. Collie DA, Sellar RJ, Zeidler M, et al. MRI of Creutzfeldt-Jakob disease: imaging features and recommended MRI protocol. Clin Radiol 2001;56:726-39.
15. Tateishi J. CJD transmitted through cadaveric dura grafts. J Clin Exp Med 1997:992-3.
16. Nakamura Y, Watanabe M, Nagoshi K. CJD associated with cadaveric dura mater grafts-Japan 1979-2003. Morb Mortal Wkly Report 2005;52:1179-81.
17. Brooke FJ, Boyd A, Klug GM, et al. Lyodura use and the risk of iatrogenic Creutzfeldt-Jakob disease in Australia. Med J Aus 2004;180:1-5.
18. Pocchiari M, Masullo C, Salvatore M, et al. Creutfeldt-Jakob disease after non-commercial dura mater graft. Lancet 1992;340:614-5.
19. Hannah EL, Belay ED, Gambetti P, et al. Creutzfeldt-Jakob disease after receipt of a previously unimplicated brand of dura mater graft. Neurology 2001;56:1080-3.
20. Sato T. CJD with dura mater transplantation. Clin Neurol 2003;43:870-2.
21. Fushimi M, Sato K, Shimizu T, et al. PLEDS in Creutzfeldt Jakob disease following a cadaveric dura graft. Clin Neurophysiol 2002;113:1030-5.
22. Nishida Y, Yamane M, Hara K, et al. Creutzfeldt-Jakob disease after Jannetta's operation with cadaveric dura mater. J Neurol 2002;249:480-3.
23. Takashima S, Tateishi J, Taguchi Y, et al. Creutzfeldt-Jakob disease with florid plaques after cadaveric dural graft in a Japanese woman. Lancet 1997;350:865-6.
24. Kimura K, Nonaka A, Tashiro H, et al. Atypical form of dural graft associated Creutzfeldt-Jakob disease: report of a postmortem case with review of the literature. J Neurol Neurosurg Psychiatry 2001;70:696-9.
25. Castilla J, Gutierrez-Adan A, Brun A, et al. Subclinical BSE infection in transgenic mice expressing porcine prion protein. J Neurosci 2004;24:5063-9.